Norges Bank’s BioTelemetry, Inc. BEAT Stock Holding History

Norges Bank’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-352,069	Closed	-$25.4M	–	2239
2020 Q4	$25.4M	Buy	352,069 +212,200	+152%	+$11.1M	0.01%	1428
2020 Q3	$6.38M	Sell	139,869 -268,643	-66%	-$11.2M	﹤0.01%	1831
2020 Q2	$18.5M	Sell	408,512 -16,763	-4%	-$751K	0.01%	1477
2020 Q1	$16.4M	Hold	425,275	–	–	0.01%	1382
2019 Q4	$19.7M	Hold	425,275	–	–	0.01%	1532
2019 Q3	$17.3M	Hold	425,275	–	–	0.01%	1550
2019 Q2	$20.5M	Buy	425,275 +207,989	+96%	+$10.9M	0.01%	1487
2019 Q1	$13.6M	Buy	+217,286	New	+$14.9M	﹤0.01%	1691

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Norges Bank's BEAT Position: Q1 2021 in Review

Norges Bank sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 352,069 shares — an estimated $25.4M sold.

Norges Bank first reported a position in BEAT in Q1 2019 and held it in 8 quarters. The position peaked at $25.4M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Norges Bank reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Norges Bank sold 352,069 BioTelemetry, Inc. shares in Q1 2021, an estimated $25.4M.
Norges Bank first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 8 quarters.
Norges Bank's BioTelemetry, Inc. position peaked at $25.4M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Norges Bank's 13F filing for Q1 2021, filed 7 May 2021.